http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Boston Scientific (BSX) to Acquire Obsidio
-
Boston Scientific Announces Acquisition of Obsidio, Inc.
-
Nevro and Boston Scientific Announce the Settlement of Their Ongoing Intellectual Property Litigations
-
Boston Scientific Announces Results for Second Quarter 2022
-
Boston Scientific Announces Conference Call Discussing Second Quarter 2022 Results
-
Boston Scientific (BSX) to Purchase Majority Stake of M.I.Tech Co., Ltd from Synergy Innovation Co., Ltd
-
Boston Scientific Announces Agreement to Purchase Majority Stake of M.I.Tech Co., Ltd from Synergy Innovation Co., Ltd
-
Boston Scientific to Participate in Bank of America Global Healthcare Conference
-
BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FIRST QUARTER 2022
-
Boston Scientific Announces Conference Call Discussing First Quarter 2022 Results
-
Boston Scientific (BSX) Announces Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device
-
Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX™ LAAC Device
-
Boston Scientific Closes Acquisition of Baylis Medical Company Inc.
-
Boston Scientific to Participate in 11th Annual SVB Leerink Global Healthcare Conference
-
BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2021
-
Boston Scientific to Present New Data on Advances in Chronic Pain Care at the 2022 North American Neuromodulation Society (NANS) Meeting
-
Boston Scientific to Participate in J.P. Morgan Healthcare Conference and Announces Conference Call Discussing Fourth Quarter 2021 Results
-
Boston Scientific Initiates Trial to Evaluate Industry's First Modular CRM System
-
Boston Scientific Announces Upcoming Conference Schedule
-
Boston Scientific Announces Results For Third Quarter 2021
-
Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Exhibits Superiority Compared to Bare Metal Stents
-
Boston Scientific (BSX) Acquires Baylis Medical Company for $1.75B
-
Boston Scientific Announces Agreement to Acquire Baylis Medical Company Inc.
-
UPDATE: Boston Scientific (BSX) Announces Positive Results for EkoSonic Endovascular System
-
Positive Late-breaking Clinical Trial Data for the EkoSonic™ Endovascular System Presented at VIVA21
-
Boston Scientific (BSX) Announces Positive Late-Breaking Clinical Trial Data for the Ranger Drug-Coated Balloon
-
Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the Ranger™ Drug-Coated Balloon
-
Boston Scientific Announces Conference Call Discussing Third Quarter 2021 Results
-
Boston Scientific (BSX) to Acquire Devoro Medical, Inc for Up to $336M
-
Boston Scientific Announces Agreement to Acquire Devoro Medical, Inc.
-
Boston Scientific's (BSX) EPOCH Trial Met Primary Endpoints, Demonstrates Improved Progression-Free Survival
-
Late-Breaking Data Demonstrate Improved Progression-Free Survival in Patients with Metastatic Colorectal Cancer After Treatment with Boston Scientific TheraSphere™ Y-90 Glass Microspheres
-
Boston Scientific Announces 2021 Investor Day Meeting
-
Boston Scientific Closes Acquisition Of Lumenis LTD. Surgical Business From Baring Private Equity Asia
-
Boston Scientific (BSX) Receives FDA Clearance for EXALT Model B Single-Use Bronchoscope
-
Boston Scientific Receives FDA Clearance for EXALT™ Model B Single-Use Bronchoscope
-
Boston Scientific Initiates Randomized Controlled Trial for the EkoSonic™ Endovascular System
-
CMS Grants Additional Reimbursement For EXALT™ Model D Single-Use Duodenoscope
-
Boston Scientific Announces Results For Second Quarter 2021
-
Boston Scientific (BSX) Announces Positive PINNACLE FLX Trial Results
-
Late-Breaking Trial Data at TVT Demonstrate Sustained Safety and Performance of WATCHMAN FLX™ Left Atrial Appendage Closure Device
-
Boston Scientific Announces Conference Call Discussing Second Quarter 2021 Results
-
Boston Scientific (BSX) Elects David S. Wichmann To Board Of Directors
-
Boston Scientific Elects David S. Wichmann To Board Of Directors
-
Boston Scientific (BSX) Uses Option to Acquire the Rest of Farapulse
-
Boston Scientific Exercises Option to Acquire Farapulse, Inc.
-
AtriCure Names Two New Members to the Board of Directors
-
Boston Scientific (BSX) Completes CE Mark for EXALT Model B Single-Use Bronchoscope
-
Boston Scientific Completes CE Mark for EXALT™ Model B Single-Use Bronchoscope
-
Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference

